The article discusses the orphan drug rule for 340B drug discount program published by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) on July 23, 2013. The regulation increases the number of entities to which pharmaceutical ...
HRSA Releases Proposed Rule Governing the Administrative Dispute Resolution Process for 340B-Related ClaimsMichael H. Hinckle
of 340B agency.]]>Reports on the United States Health Resources and Services Administration's (HRSA) overhaul of the Office of Pharmacy Affairs (OSA). Review of drug purchases; Failure of HRSA to have protocols for ensuring that entities enrolled in OSA receive appropriate discounts from drug...
HRSA Finalizes 340B Program Orphan Drug Exclusion RulesEmily J. CookDavid S. Ivill
HRSA Issues Final 340B Orphan Drug Exclusion RuleRogers, Daniel R
Richard P. Church
Christopher H. Schott
HRSA Publishes 340B Drug Pricing Program Omnibus Guidance Notice: Significant Policy Ramifications Should Trigger Public CommentJoseph W. Metro
340B Program: HRSA Posts Orphan Drug Exclusion Policy, PhRMA RespondsNatalie D. MorrisChristopher H. SchottAlice Valder Curran
HRSA Issues Interpretive Rule on 340B Drug Pricing ProgramClaire Marblestone